Awakn LS Europe Holdings Limited Patent Application Trends in 2024

From WikiPatents

Revision as of 03:34, 16 July 2024 by Wikipatents (talk | contribs) (Updating Awakn LS Europe Holdings Limited_Patent_Application_Trends_in_2024)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Contents

1 Awakn LS Europe Holdings Limited Patent Filing Activity
2 Awakn LS Europe Holdings Limited patent applications in 2024
3 Top 10 Technology Areas
4 Emerging Technology Areas
5 Top Inventors
6 Patent Categories
7 Geographical Distribution of Inventors
8 Geographical Distribution of US Inventors

Awakn LS Europe Holdings Limited Patent Filing Activity

Awakn LS Europe Holdings Limited patent applications in 2024

Top 10 Technology Areas

A61K45/06 (No explanation available)
- Count: 2 patents
- Example: 20240122895. ENTACTOGEN-ASSISTED THERAPY FOR ALCOHOL USE DISORDER AND ADDICTION-RELATED CONDITIONS AND COMORBIDITIES simplified abstract (Awakn LS Europe Holdings Limited)
A61P25/32 (No explanation available)
- Count: 2 patents
- Example: 20240122895. ENTACTOGEN-ASSISTED THERAPY FOR ALCOHOL USE DISORDER AND ADDICTION-RELATED CONDITIONS AND COMORBIDITIES simplified abstract (Awakn LS Europe Holdings Limited)
A61K9/0019 (No explanation available)
- Count: 2 patents
- Example: 20240197652. KETAMINE IN THE TREATMENT OF BEHAVIORAL ADDICTIONS simplified abstract (Awakn LS Europe Holdings Limited)
A61K47/10 (No explanation available)
- Count: 2 patents
- Example: 20240197652. KETAMINE IN THE TREATMENT OF BEHAVIORAL ADDICTIONS simplified abstract (Awakn LS Europe Holdings Limited)
A61K47/12 (No explanation available)
- Count: 2 patents
- Example: 20240197652. KETAMINE IN THE TREATMENT OF BEHAVIORAL ADDICTIONS simplified abstract (Awakn LS Europe Holdings Limited)
A61K47/32 (No explanation available)
- Count: 2 patents
- Example: 20240197652. KETAMINE IN THE TREATMENT OF BEHAVIORAL ADDICTIONS simplified abstract (Awakn LS Europe Holdings Limited)
A61P25/00 (No explanation available)
- Count: 2 patents
- Example: 20240197652. KETAMINE IN THE TREATMENT OF BEHAVIORAL ADDICTIONS simplified abstract (Awakn LS Europe Holdings Limited)
A61K31/357 (No explanation available)
- Count: 1 patents
- Example: 20240122895. ENTACTOGEN-ASSISTED THERAPY FOR ALCOHOL USE DISORDER AND ADDICTION-RELATED CONDITIONS AND COMORBIDITIES simplified abstract (Awakn LS Europe Holdings Limited)
A61K31/135 (No explanation available)
- Count: 1 patents
- Example: 20240197652. KETAMINE IN THE TREATMENT OF BEHAVIORAL ADDICTIONS simplified abstract (Awakn LS Europe Holdings Limited)
A61K9/0043 (No explanation available)
- Count: 1 patents
- Example: 20240197652. KETAMINE IN THE TREATMENT OF BEHAVIORAL ADDICTIONS simplified abstract (Awakn LS Europe Holdings Limited)

Emerging Technology Areas

C07D313/20 (No explanation available)
- Count: 1 patents
- Example: 20240190809. THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS simplified abstract (Awakn LS Europe Holdings Limited)
C07D313/06 (No explanation available)
- Count: 1 patents
- Example: 20240190809. THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS simplified abstract (Awakn LS Europe Holdings Limited)
C07D311/78 (No explanation available)
- Count: 1 patents
- Example: 20240190809. THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS simplified abstract (Awakn LS Europe Holdings Limited)
C07D307/77 (No explanation available)
- Count: 1 patents
- Example: 20240190809. THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS simplified abstract (Awakn LS Europe Holdings Limited)
C07D305/14 (No explanation available)
- Count: 1 patents
- Example: 20240190809. THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS simplified abstract (Awakn LS Europe Holdings Limited)
C07C229/50 (No explanation available)
- Count: 1 patents
- Example: 20240190809. THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS simplified abstract (Awakn LS Europe Holdings Limited)
A61P25/30 (No explanation available)
- Count: 1 patents
- Example: 20240190809. THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS simplified abstract (Awakn LS Europe Holdings Limited)
A61K47/44 (No explanation available)
- Count: 1 patents
- Example: 20240190809. THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS simplified abstract (Awakn LS Europe Holdings Limited)
A61K47/38 (No explanation available)
- Count: 1 patents
- Example: 20240190809. THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS simplified abstract (Awakn LS Europe Holdings Limited)
A61K47/36 (No explanation available)
- Count: 1 patents
- Example: 20240190809. THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS simplified abstract (Awakn LS Europe Holdings Limited)

Top Inventors

David Nutt (2 patents)
Ben Sessa (1 patent)
Laurie Higbed (1 patent)
Celia Morgan (1 patent)
Alan Borthwick (1 patent)

Patent Categories

Geographical Distribution of Inventors

Geographical Distribution of US Inventors

Awakn LS Europe Holdings Limited Inventor States 2024 - Up to June 2024

Retrieved from "http://wikipatents.org/index.php?title=Awakn_LS_Europe_Holdings_Limited_Patent_Application_Trends_in_2024&oldid=104140"